Abiopharma

🔍 BROENNIMAN EDWARD G (Director)

Company: AETHLON MEDICAL INC (AEMD)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Sold 89 shares of Common Stock at $2.19 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,915.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The Reporting Person forfeited 89 shares of common stock upon conversion of an aggregate 357 vested and outstanding restricted stock units into shares of common stock to cover tax withholdings, using the market price of the issuer's common stock at the time of forfeiture. These restricted stock units were part of the grant reported in Table I of the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on April 25, 2025.